General MedicationsORALStandard
VALPROIC ACID
VALPROIC ACID
Standard Dose
250MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview VALPROIC ACID is listed in Drugs@FDA under application 090517 (ANDA).
Marketing status: Prescription Active ingredient VALPROIC ACID Form and strength SYRUP;ORAL - 250MG/5ML Sponsor QUAGEN Submission history Latest submission status date: 2015-01-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview VALPROIC ACID is listed in Drugs@FDA under application 090517 (ANDA). Marketing status: Prescription Active ingredient VALPROIC ACID Form and strength SYRUP;ORAL - 250MG/5ML Sponsor QUAGEN Submission history Latest submission status date: 2015-01-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.